Critical Path Public Private Partnerships Clinical Trials Optional

In plain English

Food and Drug Administration (Department of Health and Human Services) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet.

Awards are up to $20,000,000 each and the agency expects to make 1 award.

Eligibility is described in the listing text (the "Others" category).

The listing says cost sharing or matching is not required.

Built only from the fields in the Grants.gov listing. Always confirm on the official listing.

• Others (see the eligibility details in the listing)

Additional eligibility information (excerpt from the listing):

Critical Path Institute

Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act . This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.

Read the full forecast on Grants.gov →